Omeros up 11% to $10.89 after AstraZeneca study failure
Omeros up 11% to $10.89 after AstraZeneca study failure
Omeros up 11% to $10.89 after AstraZeneca study failure
Omeros up 11% to $10.89 after AstraZeneca study failure
Omeros up 11% to $10.89 after AstraZeneca study failure